Abstract
The use of drug therapies in the management of acute stress reactions and chronic stress-related disorders has emerged as understanding of the pathophysiology of these conditions has become better understood. The general approach to treatment has evolved from the use of predominantly rapid-acting sedative agents for the treatment of acute anxiety attacks, to the more frequent use of agents to control the underlying anxiety disorder.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Arlington, VA: American Psychiatric Association. Available online at: http://psychiatryonline.org/guidelines.aspx.
American Psychiatric Association. (2009). Treatment of patients with panic disorder. Arlington, VA: American Psychiatric Association. Available online at: http://psychiatryonline.org/guidelines.aspx.
Brown, C., Rakel, R., Wells, B., Downs, J., & Akiskal, H. (1993). A practical update on anxiety disorders and their pharmacologic treatment. Archives of Internal Medicine, 151, 873–884.
Duman, R. S., Malberg, J., & Thome, J. (1999). Neural plasticity to stress and antidepressant treatment. Biological Psychiatry, 46, 1181–1191.
Grimsley, S. R. (1995). Anxietydisorders. In L. Y. Young, M. A. Koda-Kimble, W. A. Kradjan, & B. J. Guglielmo (Eds.), Applied therapeutics: The clinical use of drugs (6th ed., pp. 73-1–73-31). Vancouver, WA: Applied Therapeutics.
Hamilton, H., Gallagher, P., Ryan, C., Byrne, S., & O’Mahony, D. (2011). Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients. Archives of Internal Medicine, 171, 1013–1019.
Hellweg, R., Ziegenhorn, A., Heuser, I., & Deuschle, M. (2008). Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry, 41(2), 66–71.
Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biological Psychiatry, 44, 812–824.
Lorenz, R., Jackson, C. W., & Saitz, M. (2010). Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. Pharmacotherapy, 30(9), 942–951.
Schweizer, E., Rickels, K., & Lucky, I. (1986). Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. New England Journal of Medicine, 314, 719–720.
Spiegel, D. A., Wiegel, M., Baker, S. L., & Greene, K. A. I. (2000). Pharmacological management of anxiety disorders. In D. I. Mostofsky & D. H. Barlow (Eds.), The management of stress and anxiety in medical disorders (pp. 36–65). Needham Heights, MA: Allyn & Bacon.
Stahl, S. M. (2000). Essential psychopharmacotogy (2nd ed.). New York: Cambridge University Press.
The American Geriatrics Society. (2012) Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society Available online at: http://www.americangeriatrics.org/files/documents/beers/2012BeersCriteria_JAGS.pdf
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Noel, J.M., Curtis, J.L. (2013). The Pharmacological Management of Stress Reactions. In: A Clinical Guide to the Treatment of the Human Stress Response. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5538-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5538-7_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5537-0
Online ISBN: 978-1-4614-5538-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)